Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1

Status

Unknown 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1Advanced Solid Tumors 1

Interventions

Cyclophosphamide 49fludarabine 37Injections 32Gemcitabine 24Paclitaxel 23Cisplatin 21pembrolizumab 19Radiotherapy 19toripalimab 18Carboplatin 17Capecitabine 17Fluorouracil 15Oxaliplatin 14Nivolumab 13Docetaxel 12camrelizumab 11apatinib 11Temozolomide 11Cetuximab 11Immunotherapy, Adoptive 10Bevacizumab 10Irinotecan 9Drug Therapy 9Etoposide 8sintilimab 7aldesleukin 7Radiosurgery 7Peripheral Blood Stem Cell Transplantation 7Leucovorin 7Ipilimumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Unknown × SKLB1028 × Clear all
NCT05072522 2021-10-11

A Study of SKLB1028 in Patients With Advanced Solid Tumor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Unknown
98 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT02859948 2016-08-09

A Study of SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Unknown
18 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡